 |
|
 |
 |

Home > Company Index > Drugs > Drug Manufacturers - Other > Celltech Group plc
 |
Celltech Group plc |
 |
 |
 |
PROFILE |
 |
Celltech Group (formerly Celltech Chiroscience) knows birthing pangs: it has finally delivered its first two products. Chirocaine, a long-lasting local anesthetic has gone on sale in the US and the EU for use in childbirth and surgery; Mylotarg, a monoclonal antibody chemotherapy treatment for leukemia, has also been launched in the US. Celltech Group is a product of the merger of R&D firms Celltech and Chiroscience, which was followed in short order by a union with drug developer, marketer, and distributor Medeva. The transactions produced a company with a full pipeline of drug candidates (specializing in autoimmune, inflammatory, and bone diseases, cancer, and pain) and the ability to market them.
COMPETITION |
 |
Centocor, Inc. (dossier)
GlaxoSmithKline plc (GSK)
Immunex Corporation (IMNX)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 352.10
1-Yr. Sales Growth: 980.1%
Employees: 574
Revenue per employee: $613,414.63
KEY PEOPLE |
 |
Peter J. Fellner
CEO
Peter V. Allen
CFO
CONTACT INFO |
 |
216 Bath Rd.
Slough Berkshire SL1 4EN, United Kingdom
Phone: 44-1753-534-655
Fax: 44-1753-536-632
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |